DFDA

Pulmonary Rehabilitation

Treatment for Coal Workers Pneumoconiosis

Typical Dosage: 2-3 sessions/week for 8-12 weeks

Effectiveness
80%
Safety Score
95%
Clinical Trials
200
Participants
75K

Comparative Safety Scale(Higher is safer)

Cyanideâ˜ ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
2-3 sessions/week for 8-12 weeks
Time to Effect
Weeks to months
Treatment Duration
8-12 weeks initial program, then maintenance
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$200
Side Effect Mgmt:$10
Total Annual:$2,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$5,714/QALY
QALYs Gained
0.35
Outcome-Based Costs
Cost per Responder
$2,857
Prescription Access Economics
Physician Visit Cost
$250/year
Time Cost
$60/year
Travel + wait time
Insurance Admin Cost
$30/year
Prior auth, claims
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
LOW
Requires Monitoring
Yes
Needs lab work/checkups
Pulmonary Rehabilitation Outcomes

for Coal Workers Pneumoconiosis

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+70%
Common Side Effects
Musculoskeletal soreness
+5%
Fatigue
+3%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov